v3.25.3
Condensed Balance Sheets - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 1,180,426
Prepaid insurance 65,625
Prepaid expenses and other current assets 20,000
Total current assets 1,266,051
Deferred offering costs 25,000
Marketable securities held in Trust Account 175,466,068
Long-term prepaid insurance 38,140
TOTAL ASSETS 176,770,259 25,000
Current liabilities:    
Accrued expenses 30,144 766
Total current liabilities 143,489 1,087
Deferred underwriting fee payable 6,900,000
Total Liabilities 7,043,489 1,087
Commitments and Contingencies (Note 7)
Shareholders’ Equity (Deficit)    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding at September 30, 2025 and December 31, 2024
Additional paid-in capital 24,425
Accumulated deficit (5,739,873) (1,087)
Total Shareholders’ Equity (Deficit) (5,739,298) 23,913
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) 176,770,259 25,000
Class A Ordinary Shares    
Current liabilities:    
Class A ordinary shares subject to possible redemption, 17,250,000 and 0 shares at redemption value of $10.17 and $0 per share at September 30, 2025 and December 31, 2024, respectively 175,466,068
Shareholders’ Equity (Deficit)    
Ordinary shares, value
Class B Ordinary Shares    
Shareholders’ Equity (Deficit)    
Ordinary shares, value [1] 575 575
Related Party    
Current liabilities:    
Due to related party $ 113,345 $ 321
[1] At December 31, 2024, included 750,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised in full or in part by the Underwriters (see Note 6). On April 30, 2025, the Underwriters’ over-allotment option was exercised in full simultaneously with the Initial Public Offering, and the 750,000 Class B ordinary shares were no longer subject to forfeiture.